🇺🇸 FDA
Patent

US 9353117

Substituted pyrazolopyrimidines as glucocerebrosidase activators

granted A61KA61K31/519A61K31/5377

Quick answer

US patent 9353117 (Substituted pyrazolopyrimidines as glucocerebrosidase activators) held by The United States of America as Represented by the Secretary, Dept. of Health and Human Services expires Mon May 26 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as Represented by the Secretary, Dept. of Health and Human Services
Grant date
Tue May 31 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 26 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
26
CPC classes
A61K, A61K31/519, A61K31/5377, A61P, A61P43/00